A Phase 1 interventional study of brief (behavioral therapy) and Drop out re-engagement motivational intervention in Substance Abuse, sponsored by Yale University. Completed at 2 sites in United States. Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2014-09-17.
Sponsored by Yale University · Phase 1 and Interventional
We will evaluate a series of interventions intended to help individuals who drop out of substance abuse treatment re-engage in order to improve treatment outcome.
We propose a 5-year Stage I behavioral therapy development study to: 1) prospectively evaluate risk factors for premature drop-out from outpatient treatment; 2) develop and test a manual of single session phone-and office-based interventions to re-engage these individual in treatment.
2,124 studies on the registry are indexed under Substance-Related Disorders; 393 are open to participants now.
This study's enrollment of 299 is above the median of 108 across 1,727 interventional studies indexed under Substance-Related Disorders.
Browse Substance-Related Disorders studies →Yale University is the lead sponsor of 1,724 studies on the registry; 298 are open to participants now.
Of its 210 completed or terminated interventional studies of FDA-regulated products, 126 (60%) have results posted.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Standard care counselor follow up care phone calls or letters.
Behavioral: standard care follow up
Single session office based or phone based motivational counseling session designed to promote participant re-engagement in standard treatment.
Behavioral: brief (behavioral therapy) · Behavioral: Drop out re-engagement motivational intervention
up t 3 sessions of phone or office based counseling sessions to promote re-engagement in treatment.
Up to 3 phone or office based counseling sessions to promote reengagement in treatment
routine counselor phone calls and letters
retention into outpatient treatment
Time frame: 4, 8, 12, 24 weeks
substance abuse
Time frame: 4, 8,12,and 24 weeks
psychiatric symptoms
Time frame: 4, 8, 12, and 24 weeks
This study is completed, as verified in Sep 2014. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Yale University